Dr. Zhou is an experienced stem cell biologist with great passion to work on the stem cell field, especially on the application of human pluripotent stem cell (hPSC) technologies.
Dr. Zhou has been performing research with hPSCs through her whole career. As a Ph.D. student in Dr. Miguel Esteban’s laboratory at GIBH, she innovated a minimally invasive approach to generate iPSCs from different individuals, and used this technique to develop a panel of iPSC models for studying premature aging and cardiovascular diseases. In Dr. Shuibing Chen’s laboratory at Weill Cornell, Dr. Zhou worked on hPSC-derived pancreatic beta cells. Taking the full advantage of large-scale chemical screening with the hPSC-derived cells, she has explored the potential environmental triggers for diabetes, and investigated the gene-environment interactions that may underlie the etiopathology of diabetes. In addition, she has established an imaging based screening system using hPSC-derived neural progenitor cells to discover anti-Zika virus drug candidates. Besides the hPSC technologies, Dr. Zhou is also an enthusiast for the new genome editing technology, and has experienced the rapid evolution from Zinc finger nuclease mediated, TALEN mediated to CRSIRP/Cas9 mediated genome editing, and has used it extensively in her own research.
Looking forward, Dr. Zhou will continue to use her expertise to contribute to the development of the stem cell field, and she welcomes collaboration with investigators of all levels from SKI, the Tri-institutes and other institutions.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Ting Zhou discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2019 through disclosure submission in spring 2020). This data reflects interests that may or may not still exist. This data is updated annually.
View all disclosures